{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Novo Nordisk A/S"},"Symbol":{"label":"Symbol","value":"NVO"},"Address":{"label":"Address","value":"NOVO ALLE 1, BAGSVAERD, DK-2880, Denmark"},"Phone":{"label":"Phone","value":"+45 44448888"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders."},"CompanyUrl":{"label":"Company Url","value":"https://www.novonordisk.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Henrik Ehlers Wulff","title":"Executive VP-Product Supply, Quality & IT"},{"name":"Lars Fruergaard JÃ¸rgensen","title":"President & Chief Executive Officer"},{"name":"Marcus Schindler","title":"Chief Scientific Officer & Executive VP-Research"},{"name":"Maziar Mike Doustdar","title":"Executive Vice President-International Operations"},{"name":"Stephen Gough","title":"Global Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}